tiprankstipranks
Trending News
More News >
Lonza (LZAGY)
:LZAGY
Advertisement

Lonza Group (LZAGY) Price & Analysis

Compare
124 Followers

LZAGY Stock Chart & Stats

$69.92
$0.25(0.41%)
At close: 4:00 PM EST
$69.92
$0.25(0.41%)

Lonza Group News

LZAGY FAQ

What was Lonza’s price range in the past 12 months?
Lonza lowest stock price was $56.25 and its highest was $73.76 in the past 12 months.
    What is Lonza’s market cap?
    Lonza’s market cap is $44.93B.
      When is Lonza’s upcoming earnings report date?
      Lonza’s upcoming earnings report date is Jan 28, 2026 which is in 77 days.
        How were Lonza’s earnings last quarter?
        Lonza released its earnings results on Jul 23, 2025. The company reported $0.946 earnings per share for the quarter, beating the consensus estimate of $0.869 by $0.077.
          Is Lonza overvalued?
          According to Wall Street analysts Lonza’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Lonza pay dividends?
            Lonza pays a Annually dividend of $0.421 which represents an annual dividend yield of 0.64%. See more information on Lonza dividends here
              What is Lonza’s EPS estimate?
              Lonza’s EPS estimate is 1.19.
                How many shares outstanding does Lonza have?
                Lonza has 702,290,200 shares outstanding.
                  What happened to Lonza’s price movement after its last earnings report?
                  Lonza reported an EPS of $0.946 in its last earnings report, beating expectations of $0.869. Following the earnings report the stock price went up 3.024%.
                    Which hedge fund is a major shareholder of Lonza?
                    Currently, no hedge funds are holding shares in LZAGY

                    Lonza Group Stock Smart Score

                    Company Description

                    Lonza

                    Lonza Group is a global leader in the life sciences industry, providing integrated solutions to the pharmaceutical, biotechnology, and specialty ingredients markets. Headquartered in Basel, Switzerland, the company operates through two main segments: Pharma & Biotech and Specialty Ingredients. Lonza's core products and services include custom development and manufacturing of active pharmaceutical ingredients (APIs), biologics, and cell and gene therapies, as well as specialty chemicals and microbial control solutions for various industries.

                    Lonza Group (LZAGY) Earnings & Revenues

                    LZAGY Company Deck

                    LZAGY Earnings Call

                    Q2 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The earnings call highlighted strong sales growth and performance in key business segments like Integrated Biologics and Advanced Synthesis, along with an upgraded outlook for the CDMO business. However, challenges such as currency headwinds, sales decline in specialized modalities, and ongoing integration efforts in Vacaville were noted. Despite some lowlights, the strong financial performance and positive outlook suggest a generally favorable business environment.View all LZAGY earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Agilent
                    Danaher
                    Mettler-Toledo
                    Thermo Fisher
                    IQVIA Holdings

                    Ownership Overview

                    0.04%0.06%99.90%
                    Insiders
                    0.06% Other Institutional Investors
                    99.90% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis